Easywell Biomedicals, Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 419.178 million compared to TWD 374.478 million a year ago. Operating loss was TWD 235.561 million compared to TWD 326.271 million a year ago. Net loss was TWD 242.163 million compared to TWD 291.724 million a year ago. Basic loss per share was TWD 2.45 compared to TWD 3.5 a year ago.